Postpartum Hemorrhage (PPH): Difference between revisions
From Guide to YKHC Medical Practices
No edit summary |
No edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
For those patients at high risk for this (includes AMA and prior history of PPH), a few extra hemostatic agents (such as Pitocin/methergine [if BP not elevated]/Cytotec/Hemabate) should be in the delivery room. | |||
===Resources/References=== | ===Resources/References=== | ||
* [[media:PPH Grand Round - 7-2-2019.pdf|Postpartum Hemorrhage 2019]] (PowerPoint Presentation) | * [[media:PPH Grand Round - 7-2-2019.pdf|Postpartum Hemorrhage 2019]] (PowerPoint Presentation) | ||
[[OB Special Circumstances]] | [[OB Special Circumstances]] | ||
<br/>[[:Category:YKHC Guidelines|YKHC Clinical Guidelines]] | |||
Latest revision as of 09:32, 21 November 2020
For those patients at high risk for this (includes AMA and prior history of PPH), a few extra hemostatic agents (such as Pitocin/methergine [if BP not elevated]/Cytotec/Hemabate) should be in the delivery room.
Resources/References
- Postpartum Hemorrhage 2019 (PowerPoint Presentation)
